KFP
CVS icon

KMG Fiduciary Partners’s CVS Health CVS Stock Holding History

KMG Fiduciary Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,005
Closed -$271K – 292
2025
Q1 		$271K Sell
4,005
-29,658
-88% -$1.77M 0.02% 258
2024
Q4 		$1.51M Sell
33,663
-4,227
-11% -$237K 0.13% 151
2024
Q3 		$2.38M Sell
37,890
-32,402
-46% -$1.89M 0.21% 108
2024
Q2 		$4.15M Buy
70,292
+8,777
+14% +$549K 0.41% 59
2024
Q1 		$4.91M Sell
61,515
-4,080
-6% -$312K 0.51% 52
2023
Q4 		$5.18M Sell
65,595
-29,481
-31% -$2.1M 0.6% 44
2023
Q3 		$6.64M Buy
95,076
+3,350
+4% +$237K 0.88% 29
2023
Q2 		$6.34M Sell
91,726
-19,353
-17% -$1.38M 0.82% 31
2023
Q1 		$8.25M Buy
111,079
+8,383
+8% +$703K 1.18% 18
2022
Q4 		$9.57M Buy
102,696
+5,322
+5% +$514K 1.57% 10
2022
Q3 		$9.29M Buy
97,374
+14,164
+17% +$1.4M 1.79% 8
2022
Q2 		$7.71M Buy
83,210
+2,433
+3% +$237K 1.44% 14
2022
Q1 		$8.18M Buy
80,777
+1,137
+1% +$119K 1.31% 17
2021
Q4 		$8.22M Buy
79,640
+7,286
+10% +$673K 1.27% 16
2021
Q3 		$6.14M Buy
72,354
+2,725
+4% +$228K 1.04% 25
2021
Q2 		$5.81M Buy
69,629
+2,521
+4% +$206K 1.03% 25
2021
Q1 		$5.05M Buy
67,108
+6,158
+10% +$449K 0.98% 27
2020
Q4 		$4.29M Buy
60,950
+8,609
+16% +$560K 0.91% 31
2020
Q3 		$3.06M Buy
52,341
+15,104
+41% +$940K 0.76% 39
2020
Q2 		$2.42M Buy
37,237
+5,822
+19% +$367K 0.67% 44
2020
Q1 		$1.86M Buy
31,415
+16,134
+106% +$1.08M 0.61% 48
2019
Q4 		$1.14M Sell
15,281
-9,145
-37% -$642K 0.35% 53
2019
Q3 		$1.54M Buy
24,426
+7,313
+43% +$433K 0.52% 40
2019
Q2 		$932K Buy
17,113
+2,037
+14% +$110K 0.34% 58
2019
Q1 		$813K Buy
+15,076
New +$931K 0.31% 59

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

KMG Fiduciary Partners's CVS Position: Q2 2025 in Review

KMG Fiduciary Partners sold out of CVS Health (CVS) in Q2 2025, closing a stake of 4,005 shares — an estimated $271K sold.

KMG Fiduciary Partners first reported a position in CVS in Q1 2019 and held it in 25 quarters. The position peaked at $9.57M in Q4 2022. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • KMG Fiduciary Partners reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • KMG Fiduciary Partners sold 4,005 CVS Health shares in Q2 2025, an estimated $271K.
  • KMG Fiduciary Partners first reported a position in CVS Health in Q1 2019 and held it in 25 quarters.
  • KMG Fiduciary Partners's CVS Health position peaked at $9.57M in Q4 2022.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on KMG Fiduciary Partners's 13F filing for Q2 2025, filed 10 Jul 2025.